Scientists have discovered two potent human antibodies that can stop more than 90 percent of known HIV strains from infecting human cells in the laboratory, and have demonstrated how one of these disease-fighting proteins accomplishes this. According to the scientists, these antibodies could be used to design improved HIV vaccines, or further developed to prevent or treat HIV infection. Moreover, the method used to find these antibodies could be applied to isolate therapeutic antibodies for other infectious diseases.